Publications by authors named "Alexis Benjamin Cortot"
Page 1 of 1
Synopsis of recent research by authors named "Alexis Benjamin Cortot"
- Alexis Benjamin Cortot's recent research primarily focuses on advanced non-small-cell lung cancer (NSCLC), specifically targeting treatment efficacy and safety in patients with unique challenges, such as ALK-positive tumors and brain metastases.
- His work includes a multicenter study that evaluated the long-term efficacy of brigatinib, an ALK inhibitor, in pretreated ALK-positive advanced NSCLC patients, highlighting its effectiveness and the subsequent response to lorlatinib post-treatment.
- Additionally, Cortot explored the feasibility and outcomes of salvage immunotherapy using pembrolizumab for hospitalized NSCLC patients facing severe complications, assessing overall survival and discharge rates, thus addressing an important gap in treatment for this vulnerable patient population.
